Sai Life Sciences Limited IPO
Sai Life Sciences Limited was a mainboard IPO in the Pharmaceuticals sector, offered at ₹522–₹549 per share to raise ₹3,043 crore. The issue was subscribed 10.26× overall (QIBs 30.93×, NIIs 4.92×, retail 1.37×). It listed on 18 Dec 2024 at ₹650 and closed its first day at ₹765, a listing gain of +39.3% versus the ₹549 issue price. It now trades around ₹1,558 (+183.7% versus the issue price).
Frequently asked questions
- How many times was the Sai Life Sciences Limited IPO subscribed?
- The Sai Life Sciences Limited IPO was subscribed 10.26× overall — 30.93× in the QIB category, 4.92× among non-institutional investors, 1.37× in retail.
- What were the Sai Life Sciences Limited IPO listing gains?
- Sai Life Sciences Limited listed on 18 Dec 2024 at ₹650, closing its first day at ₹765 — a listing gain of +39.3% versus the ₹549 issue price.
- What were the retail allotment odds for the Sai Life Sciences Limited IPO?
- Retail was subscribed 1.37×, so a single-lot application had roughly a 73% chance of allotment — most applicants were allotted, and allotment was finalised on 16 Dec 2024.
- What was the price band and lot size of the Sai Life Sciences Limited IPO?
- The price band was ₹522–₹549 per share, with a minimum lot of 27 shares (₹14,823 at the upper band).
- Who were the registrar and lead manager for the Sai Life Sciences Limited IPO?
- KFin Technologies Limited was the registrar, and Kotak Mahindra Capital was the book-running lead manager.